AI Predicts Bowel Cancer Drug Response for NHS Patients
A new AI tool, PhenMap, developed by researchers in London and Dublin, predicts how advanced bowel cancer patients respond to the NHS drug bevacizumab, potentially sparing thousands from ineffective treatments and severe side-effects.


